EcoR1 Capital, LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$3.3T
Holdings
55
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (55 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APLSAPELLIS PHARMACEUTICALS INC | 11,607,425 | $445.3B | 13.62% | |
| 2 | PRTAPROTHENA CORP PLC | 11,584,280 | $239.1B | 7.31% | |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 1,407,322 | $222.4B | 6.80% | |
| 4 | ANABANAPTYSBIO INC | 7,521,024 | $188.5B | 5.77% | |
| 5 | CRNXCRINETICS PHARMACEUTICALS IN | 4,155,375 | $186.1B | 5.69% | |
| 6 | ARVNARVINAS INC | 6,726,491 | $179.1B | 5.48% | |
| 7 | MORFMORPHIC HLDG INC | 4,982,945 | $169.8B | 5.19% | |
| 8 | GLPGGALAPAGOS NV | 5,756,268 | $142.6B | 4.36% | |
| 9 | KURAKURA ONCOLOGY INC | 5,806,871 | $119.6B | 3.66% | |
| 10 | TNGXTANGO THERAPEUTICS INC | 13,330,736 | $114.4B | 3.50% | |
| 11 | ZYMEZYMEWORKS INC | 13,437,473 | $114.4B | 3.50% | |
| 12 | JAZZJAZZ PHARMACEUTICALS PLC | 1,013,952 | $108.2B | 3.31% | |
| 13 | XNCRXENCOR INC | 5,330,416 | $100.9B | 3.09% | |
| 14 | CRSPCRISPR THERAPEUTICS AG | 1,389,276 | $75.0B | 2.30% | |
| 15 | JANXJANUX THERAPEUTICS INC | 1,469,818 | $61.6B | 1.88% | |
| 16 | NUVBNUVATION BIO INC | 19,209,643 | $56.1B | 1.72% | |
| 17 | CNTACENTESSA PHARMACEUTICALS PLC | 5,714,404 | $51.6B | 1.58% | |
| 18 | 5E7ITEOS THERAPEUTICS INC | 3,249,835 | $48.2B | 1.48% | |
| 19 | IMNMIMMUNOME INC | 3,879,415 | $46.9B | 1.44% | |
| 20 | NGNENEUROGENE INC | 1,271,342 | $46.3B | 1.42% | |
| 21 | THRDTHIRD HARMONIC BIO INC | 3,182,444 | $41.4B | 1.27% | |
| 22 | —MERSANA THERAPEUTICS INC | 19,364,688 | $38.9B | 1.19% | |
| 23 | VYGRVOYAGER THERAPEUTICS INC | 3,917,546 | $31.0B | 0.95% | |
| 24 | RNAAVIDITY BIOSCIENCES INC | 757,576 | $30.9B | 0.95% | |
| 25 | TCRXTSCAN THERAPEUTICS INC | 5,000,000 | $29.3B | 0.89% | |
| 26 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 27,404,070 | $26.7B | 0.82% | |
| 27 | ORICORIC PHARMACEUTICALS INC | 3,418,068 | $24.2B | 0.74% | |
| 28 | CRGXCARGO THERAPEUTICS INC | 1,470,000 | $24.1B | 0.74% | |
| 29 | TCE2CELLDEX THERAPEUTICS INC | 650,000 | $24.1B | 0.74% | |
| 30 | PCVXVAXCYTE INC | 300,000 | $22.7B | 0.69% | |
| 31 | EWTXEDGEWISE THERAPEUTICS INC | 1,250,385 | $22.5B | 0.69% | |
| 32 | ACADACADIA PHARMACEUTICALS INC | 1,346,475 | $21.9B | 0.67% | |
| 33 | LENZLENZ THERAPEUTICS INC | 1,219,774 | $21.1B | 0.65% | |
| 34 | MDGLMADRIGAL PHARMACEUTICALS INC | 75,000 | $21.0B | 0.64% | |
| 35 | NMRANEUMORA THERAPEUTICS INC. | 2,071,450 | $20.4B | 0.62% | |
| 36 | BCYCBICYCLE THERAPEUTICS PLC | 910,000 | $18.4B | 0.56% | |
| 37 | AVIRATEA PHARMACEUTICALS INC | 5,441,896 | $18.0B | 0.55% | |
| 38 | PHVSPHARVARIS N V | 900,000 | $16.9B | 0.52% | |
| 39 | DYNDYNE THERAPEUTICS INC | 427,039 | $15.1B | 0.46% | |
| 40 | TECXTECTONIC THERAPEUTIC INC | 849,143 | $14.0B | 0.43% | |
| 41 | RCKTROCKET PHARMACEUTICALS INC | 508,393 | $10.9B | 0.33% | |
| 42 | KROSKEROS THERAPEUTICS INC | 187,500 | $8.6B | 0.26% | |
| 43 | —ALLOVIR INC | 11,294,585 | $8.2B | 0.25% | |
| 44 | REPLREPLIMUNE GROUP INC | 850,341 | $7.7B | 0.23% | |
| 45 | VERVVERVE THERAPEUTICS INC | 1,250,000 | $6.1B | 0.19% | |
| 46 | GBIOGBXGENERATION BIO CO | 2,046,867 | $5.8B | 0.18% | |
| 47 | PRMEPRIME MEDICINE INC | 700,000 | $3.6B | 0.11% | |
| 48 | ATRAATARA BIOTHERAPEUTICS INC | 406,679 | $3.5B | 0.11% | |
| 49 | PRQRPROQR THRAPEUTICS N V | 2,042,771 | $3.4B | 0.10% | |
| 50 | HOOKGBPHOOKIPA PHARMA INC | 5,717,324 | $3.4B | 0.10% | |
| 51 | KYTXKYVERNA THERAPEUTICS INC | 450,000 | $3.4B | 0.10% | |
| 52 | NUVB/WSNUVATION BIO INC | 963,333 | $2.8B | 0.09% | |
| 53 | ALGSALIGOS THERAPEUTICS INC | 6,389,468 | $2.2B | 0.07% | |
| 54 | SRZNWSURROZEN INC | 66,665 | $730.0M | 0.02% | |
| 55 | —CAREMAX INC | 100,000 | $279.0M | 0.01% |